UK presses ahead with plain packaging

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

UK presses ahead with plain packaging

The UK government will propose legislation to introduce plain packaging for cigarettes within the next two months, meaning it would come into force next year

Public health minister Jane Ellison announced the move, which follows extensive consultation. It will be a free vote, meaning MPs can vote how they wish, irrespective of party lines, and the decision will apply in England, but not Wales, Scotland or Northern Ireland.

Evidence received suggested that plain packaging would improve public health and reduce the number of smokers.

But cigarette companies are likely to strongly oppose the plans, arguing that they damage their trade mark rights, and infringe Article 17 of the EU Charter of Fundamental Rights.

All of the major tobacco companies in the UK said they will challenge plain packaging, according to a report in the Financial Times (subscription required).

Australia is the only country to introduce plain packaging so far. Its law led to a challenge at the WTO.

For more details, see our tobacco trade marks topic page.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Schwitulla is the head of litigation management at Nokia in Germany
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article